AbbVie Inc (ABBV) Stock Price Today
Aura AI Summary
Key Stats
- $443.23BMarket Cap
- -Volume
- HealthSector
- $263.5852W High
- $197.3852W Low
- -Typical Hold Time
- $507.48BEnterprise Value
- 2.76%Div Yield
- -Trading Activity
Track AbbVie Inc (ABBV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbbVie Inc has traded between a low of $197.38 and a high of $263.58, highlighting its annual price range. Buy and sell AbbVie Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Most Recent News
Airbus leads aerospace market with strong orders despite production challenges
Airbus is outperforming Boeing in commercial aircraft orders, securing 821 net orders in H1 2026 compared to Boeing's 408. Morgan Stanley maintains an "Overweight" rating on Airbus, raising its price target to €255, reflecting confidence in the compa...

OpenAI nears $40B revenue but sees two top execs exit amid $7B employee share sale.
OpenAI is on track to exceed $40 billion in annual revenue, doubling its pace from last year, yet two senior executives recently announced departures. These exits coincide with a $7 billion secondary sale of employee shares, providing liquidity that ...

C3.ai shares fall amid revenue drop; Wedbush bets on 47% rebound led by CEO Siebel's turnaround plan.
C3.ai's stock trades at $10.18 after a steep revenue decline of 35.67% in fiscal 2026 and a gross margin collapse. Despite this, Wedbush analyst Dan Ives sets a high price target of $15, citing growth potential in federal AI bookings and partnerships...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.